These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16513226)

  • 1. Starch microparticles as a vaccine adjuvant: only uptake in Peyer's patches decides the profile of the immune response.
    Stertman L; Lundgren E; Sjöholm I
    Vaccine; 2006 Apr; 24(17):3661-8. PubMed ID: 16513226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice.
    Stertman L; Strindelius L; Sjöholm I
    Vaccine; 2004 Jul; 22(21-22):2863-72. PubMed ID: 15246622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic stress on the immune response to oral human serum albumin-conjugated starch microparticles in rats.
    Keita AV; Stertman L; Sun YQ; Larhed A; Sjöholm I; Söderholm JD
    J Neuroimmunol; 2007 Feb; 183(1-2):33-42. PubMed ID: 17174407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa.
    Larhed A; Stertman L; Edvardsson E; Sjöholm I
    J Drug Target; 2004 Jun; 12(5):289-96. PubMed ID: 15512780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice.
    Strindelius L; Folkesson A; Normark S; Sjöholm I
    Vaccine; 2004 Mar; 22(11-12):1448-56. PubMed ID: 15063568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response.
    Koster FT; Pierce NF
    J Immunol; 1983 Jul; 131(1):115-9. PubMed ID: 6190901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice.
    Wikingsson L; Sjöholm I
    Vaccine; 2002 Sep; 20(27-28):3355-63. PubMed ID: 12213405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization.
    Singh P; Prabakaran D; Jain S; Mishra V; Jaganathan KS; Vyas SP
    Int J Pharm; 2004 Jul; 278(2):379-90. PubMed ID: 15196642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic phenotype of hosts orally immunized with corneal alloantigens.
    Ma D; Li XY; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):744-53. PubMed ID: 9538881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant effects of cholera toxin b subunit on immune response to recombinant thyrotropin receptor in mice.
    Fan JL; Peterson JW; Prabhakar BS
    J Autoimmun; 2000 Feb; 14(1):43-52. PubMed ID: 10648115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhinoVax is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant.
    Mayo SL; Tufvesson M; Carlsson HE; Royo F; Gizurarson S; Hau J
    In Vivo; 2005; 19(2):375-82. PubMed ID: 15796200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural study of liposome uptake by M cells of rat Peyer's patch: an oral vaccine system for delivery of purified antigen.
    Childers NK; Denys FR; McGee NF; Michalek SM
    Reg Immunol; 1990; 3(1):8-16. PubMed ID: 2223559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A; Katare OP; Singh B; Vyas SP
    Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.